Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000771856-25-000009
Filing Date
2025-08-22
Accepted
2025-08-22 15:20:16
Documents
18
Period of Report
2025-08-22

Document Format Files

Seq Description Document Type Size
1 DEF 14A csbr-20250822.htm   iXBRL DEF 14A 451978
6 csbr-20250822_g1.jpg GRAPHIC 95974
7 csbr-20250822_g2.jpg GRAPHIC 85421
8 csbr-20250822_g3.jpg GRAPHIC 5043
  Complete submission text file 0000771856-25-000009.txt   1373298

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT csbr-20250822.xsd EX-101.SCH 2393
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT csbr-20250822_def.xml EX-101.DEF 2421
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT csbr-20250822_lab.xml EX-101.LAB 2810
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT csbr-20250822_pre.xml EX-101.PRE 1502
20 EXTRACTED XBRL INSTANCE DOCUMENT csbr-20250822_htm.xml XML 73000
Mailing Address 855 N. WOLFE STREET SUITE 619 BALTIMORE MD 21205
Business Address 855 N. WOLFE STREET SUITE 619 BALTIMORE MD 21205 410-369-0365
CHAMPIONS ONCOLOGY, INC. (Filer) CIK: 0000771856 (see all company filings)

EIN.: 521401755 | State of Incorp.: DE | Fiscal Year End: 0430
Type: DEF 14A | Act: 34 | File No.: 001-11504 | Film No.: 251245969
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)